高盛:维持信义光能(0968.HK)目标价25港元 评级“买入”
高盛发表研究报告指,信义光能(0968.HK)去年收入123亿港元,按年上升35.4%,纯利45.6亿港元,按年上升89%,高于该行预期5%,维持集团目标价25港元及“买入”评级。
高盛表示,集团去年太阳能玻璃的销售收入99.9亿港元,按年增48%,而由于产能扩张,太阳能玻璃销量按年增长19.6%。集团管理层预料,今年上半年原材料成本将较去年稳定。集团亦有急速扩张的计划,料太阳能玻璃的均价将因额外的供应量增加而下降。
该行考虑到集团去年业绩及由于整个行业的产能增加而导致的潜在价格下降,将2021-2025财年的盈利预测下调最多8%。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.